top of page

Yogita Dhas, PhD

Content writer – Clinical

Yogita Dhas is a Clinical Content Writer at Rhenix. She is responsible for writing scientific content and clinical white papers on healthcare-related topics, focusing mainly on oncology and immunology.

 

Yogita has a doctoral degree in life sciences from Symbiosis International (Deemed University), Pune, and her research work focused on diabetes and vitamin D.

 

At Rhenix, she has attained experience in scientific writing.

Stories

Summary "A six-metabolite panel as potential blood-based biomarkers for Parkinson’s disease"

Parkinson’s disease (PD) is the second most common neurodegenerative disease after Alzheimer’s disease (AD) and affects around five million people worldwide. People with PD typically exhibit symptoms when 50%...

Parkinson's disease.jpg

Summary "Grading of IDH‑mutant astrocytoma using diffusion, susceptibility, and perfusion‑weighted imaging"

The accurate grading of IDH-mutant astrocytoma is essential to develop therapeutic strategies and evaluating the prognosis of patients. A preoperative classification of these entities could be beneficial for the treatments...

Astrocytoma

Summary "Phase 2 study of pembrolizumab in patients with recurrent and residual high-grade meningiomas."

Meningiomas are the most prevalent primary central nervous system tumor, with a prevalence of 170,000 cases in the United States. Maximal safe resection is the cornerstone of meningioma treatment, and adjuvant radiation...

Meningioma.jpg

Summary "Easy-to-find irAEs can be used as indicators to predict neoadjuvant chemo-immunotherapy response."

Lung cancer is the prominent cause of cancer-related deaths worldwide. Non-small cell lung cancer (NSCLC) patients are diagnosed with early-stage disease in only 25% of cases, making them amenable to...

Lung Cancer

Summary "Long-term impact of metformin and sulphonylurea therapies on type 2 diabetes: A two-decade analysis of survival patterns."

Metformin is a first-line drug used for type 2 diabetes (T2D) treatment. Metformin has been associated with other non-diabetic health benefits, such as extending a healthy lifespan, in addition to its main use in the treatment...

Long-term effects of metformin on longevity

Summary "Physical and mental stress: Impact on lifespan."

Stress, whether physical or mental, plays a pivotal role in determining the quality and length of human life. Physical stress triggers predictable responses in tissues, organs, and systems, with chronic exposure leading to the...

Impact on lifespan

Summary "Aging - What is it? How to prevent it?"

Aging is the time-related deterioration of physiological functions crucial for survival and fertility, marked by the gradual accumulation of cellular and molecular damage. It is a major risk factor for chronic diseases...

Aging and longevity

Videos

A six-metabolite panel as potential blood-based biomarkers for Parkinson’s disease | CellTalk

Parkinson’s disease (PD) is the second most common neurodegenerative disease after Alzheimer’s disease (AD) and affects around five million people worldwide. People with PD typically exhibit symptoms when 50%...

Grading of IDH‑mutant astrocytoma using diffusion, susceptibility, and perfusion‑weighted imaging | CellTalk

The accurate grading of IDH-mutant astrocytoma is essential to develop therapeutic strategies and evaluating the prognosis of patients. A preoperative classification of these entities could be beneficial for the treatments of patients, particularly...

Phase 2 study of pembrolizumab in patients with recurrent and residual high-grade meningiomas | CellTalk

Meningiomas are the most prevalent primary central nervous system tumor, with a prevalence of 170,000 cases in the United States. Maximal safe resection is the cornerstone of meningioma treatment, and adjuvant radiation may be...

Easy-to-find irAEs can be used as indicators to predict neoadjuvant chemo-immunotherapy response | CellTalk

Lung cancer is the prominent cause of cancer-related deaths worldwide. Non-small cell lung cancer (NSCLC) patients are diagnosed with the early-stage disease in only 25% of cases, making them amenable to surgery with a curative goal. The development...

Long-term impact of metformin and sulphonylurea therapies on type 2 diabetes: A two-decade analysis of survival patterns | CellTalk

Metformin is a first-line drug used for type 2 diabetes (T2D) treatment. Metformin has been associated with other non-diabetic health benefits, such as extending a healthy lifespan, in addition to its main use in the treatment of...

Physical and mental stress: Impact on lifespan | CellTalk

Stress, whether physical or mental, plays a pivotal role in determining the quality and length of human life. Physical stress triggers predictable responses in tissues, organs, and systems, with chronic exposure leading to the...

Aging - What is it? How to prevent it? | CellTalk

This presentation elaborates on the relationship between calorie restriction and its potential impact on aging processes. Aging is defined as the time-related deterioration of physiological functions, posing a major risk for chronic diseases. Hallmarks of aging...

Connecting Dots

Get the latest updates

Join Celltalk!

Subscribe us today & receive latest updates on your mail !

bottom of page